Your session is about to expire
← Back to Search
Study Summary
This trial will look into how a new drug affects people with Type 1 Diabetes to regulate their blood sugar.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 4 trial • 368 Patients • NCT02008682Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have had surgery to help you lose weight.Your diabetes is not well controlled.Adults with Type 1 diabetes, whether male or female.Your body mass index (BMI) is between 25 and 35.You have been using an insulin pump or giving yourself multiple daily injections for at least 3 months.You have had type 1 diabetes for at least 3 years.You have had cancer in the past.You are between 18 and 65 years old.
- Group 1: Victoza
- Group 2: CT-868
- Group 3: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment seeking out participants that are more than 35 years of age?
"The age requirements for this research experiment necessitate that participants be at least 18 years old and not exceed 65."
What are the eligibility requirements to join this research program?
"To be accepted for this trial, participants must have type 1 diabetes and fall between 18-65 years old. Currently, 24 individuals are sought after to fill the study participation slots."
Is there a potential risk posed by CT-868 to the general public?
"Taking into account the limited amount of evidence available, our team at Power gave CT-868 a score of 1 on the safety scale. This is because it's currently undergoing Phase One trials where both efficacy and safety are being experimentally tested."
What is the current number of individuals participating in this clinical experiment?
"Affirmative. According to information provided on clinicaltrials.gov, this trial is actively in search of suitable candidates as it was initially posted on March 1st 2023 and edited most recently on the 30th of that same month. A total 24 patients are needed across a single medical centre."
Could you tell me if this experiment is currently recruiting participants?
"Per the information on clinicaltrials.gov, this study is currently in search of participants. It was first made public on March 1st 2023 and last edited 30 days later."
Share this study with friends
Copy Link
Messenger